Navigation Links
Pediatrician creates easier way to identify kids' high BP
Date:5/25/2009

Pediatricians now have a new and simple way to diagnose a serious problem facing our nation's children thanks to David Kaelber, M.D., Ph.D., M.P.H., MetroHealth System pediatrician, internist, and chief medical informatics officer and Case Western Reserve University School of Medicine researcher and faculty member. Nearly 75% of cases of hypertension and 90% of cases of prehypertension in children and adolescents go undiagnosed. These troubling statistics were documented in previously published research by Dr. Kaelber. From this research, Dr. Kaelber and fellow researchers felt that one of the main reasons for the under-diagnosis may be due to the complex chart currently used to help physicians and medical personnel identify high blood pressure in children. So Dr. Kaelber's team simplified the chart focusing solely on a child's age and gender eliminating the need for a height percentile and reducing the number of values in the blood pressure table from 476 to just 64. The revised chart and accompanying description are published in the June issue of the journal Pediatrics.

The American Academy of Pediatrics and the American Heart Association recommend that blood pressure checks be done at all pediatric visits for health care (including dental and optometric appointments) for children ages 3 to 18. The current standard chart used by healthcare providers to evaluate pediatric blood pressure is from the National Heart, Lung, and Blood Institute and includes hundreds of normal and abnormal blood pressure values. In order to differentiate between normal and abnormal readings, providers need to, not only remember the variety of blood pressure ranges, but also know the child's height percentile which can be difficult to verify, especially in non-primary care settings.

In re-designing the chart, Dr. Kaelber's team reduced the systolic and diastolic blood pressure cutoff values to one value for girls and one value for boys for each year of life from ages 3 to 18 plus. Researchers used the lower limit of height (5th percentile) in the abnormal blood pressure range for a given gender and age. While they note this may incorrectly flag some taller children as being in the abnormal blood pressure range, the researchers predict this number will be small compared to the number of children with prehypertension and hypertension who are identified. Any reading at or above the listed numbers in the chart will indicate a child who needs further evaluation by a physician.

"We know that children with high blood pressure often become adults with heart disease and other serious medical conditions," says Dr. Kaelber. "Anything that helps health care providers in identifying this life-threatening condition early is essential. The long-term solution will no doubt involve electronic medical records and other electronic tools, but until that is available in all healthcare settings, this simplified table should be a helpful screening tool."


'/>"/>

Contact: Jessica Studeny
jessica.studeny@case.edu
216-368-4692
Case Western Reserve University
Source:Eurekalert

Related medicine news :

1. SkinMedica to Co-Promote ACZONE(R) (dapsone) Gel 5% to Pediatricians in the U.S.
2. Cetaphil(R) Cleansers and Moisturizers Now the #1 Pediatrician Recommended Brand
3. American College of Pediatricians: Another Blow to Childrens Rights
4. Renowned Pediatrician Joins Fight for Epilepsy Awareness for Purple Day
5. RSV to Blame for 1 in 13 Pediatrician Visits
6. Survey could help pediatricians better treat patients
7. Dr. Alan Greene: The Organic Man -- Renowned Pediatrician Marks Third Anniversary of Organic-Only Diet
8. Pediatricians Could Help Screen for Alcohol Abuse in Home
9. Parents comfortable with alcohol screening in pediatricians offices
10. NO on Prop 8 Campaign Releases Statement by 300 California Pediatricians
11. Lupin Enters into a Marketing Alliance with Forest Laboratories, Inc. for AeroChamber Plus(R) Brand in the US - Extends its Franchise with Pediatricians
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2016)... ... December 03, 2016 , ... The Lymphoma Research Foundation ... research and serving the lymphoma community through a comprehensive series of education programs, ... Event in New York City, with long-time partners The Paul Foundation, on November ...
(Date:12/4/2016)... Aliso Viejo, California (PRWEB) , ... December 04, ... ... self-animating lower third presets that have new attractive animation styles with unique displacement ... Pro3rd Displace features 30 pre-animated lower third designs. Choose from a variety of ...
(Date:12/2/2016)... , ... December 02, 2016 , ... Lori G. ... Traurig, LLP’s Atlanta office, will speak at the American Conference Institute’s 21st Drug ... Traurig is also a Lead Sponsor of the conference. , Cohen, who chairs the ...
(Date:12/2/2016)... ... December 02, 2016 , ... Advanced Inc., a leading provider of ... Bice, CPA, MBA to serve as Advanced Inc.’s Chief Financial Officer, effective December 1, ... Jason brings extensive financial and operational leadership experience to Advanced Inc. He began his ...
(Date:12/2/2016)... PA (PRWEB) , ... December 02, 2016 , ... With ... struggling through rehabilitation of an injury, patients must find the one that works for ... his pain, he created a machine that worked and decided to share it with ...
Breaking Medicine News(10 mins):
(Date:12/4/2016)...   Pairnomix, LLC, a genetic research company and ... the White House, today announced that findings from its first ... candidate therapies for a patient with epileptic encephalopathy caused by ... at the 70 th Annual Meeting of the ... , December 2-6, 2016.  Pairnomix, unique process involves ...
(Date:12/4/2016)... EAST HANOVER, N.J. , Dec. 3, 2016 /PRNewswire/ ... SEG101 (crizanlizumab, formerly SelG1), an anti-P-selectin antibody, reduced the ... by 45.3% compared to placebo (1.63 vs 2.98, p=0.010) ... Novartis today announced that the data are being featured ... American Society of Hematology (ASH) Annual Meeting and ...
(Date:12/4/2016)... Dec. 3, 2016  Findings from a Novartis ... CTL019, an investigational chimeric antigen receptor T cell ... young adult patients with B-cell acute lymphoblastic leukemia ... session at the 58th American Society of Hematology ... p.m.). The global Phase II study found that ...
Breaking Medicine Technology: